The World of Multiple Sclerosis - Int'l Fed. of Multiple Sclerosis Societies (UK)
The Myelin Project - Washington DC (US)
Nat'l Multiple Sclerosis Society (US)
Review Multiple Sclerosis - NeuroWeb Forum, Mass. Gen. Hosp (US)
MEDLINE
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 1993 Apr;43(4):662-7
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet 1998 Nov 7;352(9139):1491-7
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 1998 Nov 7;352(9139):1498-504
Association of human herpes virus 6 (HHV-6) with multiple sclerosis:increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997 Dec;3(12):1394-7. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. Viral Immunology Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland 20892, USA